Bank Of New York Mellon Corp Eyenovia, Inc. Transaction History

Bank Of New York Mellon Corp

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$1.72 - $3.53 $77,539 - $159,135	45,081 New	45,081 $159 Million
Q4 2022 Feb 14, 2023	BUY	$1.54 - $2.74 $68,335 - $121,584	44,374 New	44,374 $72,000
Q3 2022 Nov 14, 2022	BUY	$1.55 - $2.48 $1,393 - $2,229	899 Added 2.02%	45,510 $89,000
Q2 2022 Aug 15, 2022	SELL	$1.71 - $3.26 $1,733 - $3,305	-1,014 Reduced 2.22%	44,611 $87,000
Q4 2021 Feb 11, 2022	BUY	$3.5 - $6.58 $91,619 - $172,244	26,177 Added 134.6%	45,625 $183,000
Q2 2021 Aug 11, 2021	SELL	$4.36 - $5.75 $7,433 - $9,803	-1,705 Reduced 8.06%	19,448 $96,000
Q1 2021 May 13, 2021	SELL	$5.11 - $7.41 $9,433 - $13,678	-1,846 Reduced 8.03%	21,153 $108,000
Q4 2020 Feb 09, 2021	BUY	$3.11 - $6.06 $2,404 - $4,684	773 Added 3.48%	22,999 $139,000
Q2 2020 Aug 12, 2020	SELL	$2.6 - $3.81 $2 - $3	-1 Reduced -0.0%	22,226 $63,000
Q1 2020 May 06, 2020	SELL	$1.77 - $4.92 $297 - $826	-168 Reduced 0.75%	22,227 $51,000
Q1 2019 May 14, 2019	BUY	$2.63 - $6.3 $25,947 - $62,155	9,866 Added 78.75%	22,395 $134,000
Q4 2018 Feb 11, 2019	BUY	$2.6 - $4.24 $32,575 - $53,122	12,529 New	12,529 $36,000

13.4M

13.1K

21.3K

Ticker EYEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,212,900
Market Cap $3.42M
Description
Eyenovia, Inc., a clinical stage ophthalmic company, engages in developing therapeutics based on its proprietary microdose array print platform technology. The company focuses on developing clinical microdosing of formulations of ophthalmic pharmaceutical agents using its Optejet branded targeted ocular delivery system. It focuses on the develop...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.